200 related articles for article (PubMed ID: 18402650)
1. The trials and tribulations of drug development for functional gastrointestinal disorders.
Chang L
Neurogastroenterol Motil; 2008 May; 20 Suppl 1():130-8. PubMed ID: 18402650
[TBL] [Abstract][Full Text] [Related]
2. Challenges in drug development for functional gastrointestinal disorders. Part I: functional dyspepsia.
Andresen V; Camilleri M
Neurogastroenterol Motil; 2006 May; 18(5):346-53. PubMed ID: 16629861
[TBL] [Abstract][Full Text] [Related]
3. Challenges in drug development for functional gastrointestinal disorders. Part II: visceral pain.
Andresen V; Camilleri M
Neurogastroenterol Motil; 2006 May; 18(5):354-60. PubMed ID: 16629862
[TBL] [Abstract][Full Text] [Related]
4. How to improve drug development for functional disorders.
Tack J; Corsetti M
Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):787-96. PubMed ID: 15324714
[TBL] [Abstract][Full Text] [Related]
5. Design of treatment trials for functional gastrointestinal disorders.
; Irvine EJ; Whitehead WE; Chey WD; Matsueda K; Shaw M; Talley NJ; Veldhuyzen van Zanten SJ
Gastroenterology; 2006 Apr; 130(5):1538-51. PubMed ID: 16678567
[TBL] [Abstract][Full Text] [Related]
6. The use of genomics in clinical trial design.
Simon R
Clin Cancer Res; 2008 Oct; 14(19):5984-93. PubMed ID: 18829477
[TBL] [Abstract][Full Text] [Related]
7. Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders.
Pasricha PJ
Gastroenterology; 2007 Jun; 132(7):2287-90. PubMed ID: 17570201
[No Abstract] [Full Text] [Related]
8. Functional gastrointestinal disorders: an update for the psychiatrist.
Jones MP; Crowell MD; Olden KW; Creed F
Psychosomatics; 2007; 48(2):93-102. PubMed ID: 17329601
[TBL] [Abstract][Full Text] [Related]
9. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
10. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in early cancer drug development: limited utility.
Glassman RH; Ratain MJ
Clin Pharmacol Ther; 2009 Feb; 85(2):134-5. PubMed ID: 19151638
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders.
Camilleri M; Bueno L; de Ponti F; Fioramonti J; Lydiard RB; Tack J
Gastroenterology; 2006 Apr; 130(5):1421-34. PubMed ID: 16678556
[TBL] [Abstract][Full Text] [Related]
13. Development of drugs for gastrointestinal motor disorders: translating science to clinical need.
Sanger GJ; Alpers DH
Neurogastroenterol Motil; 2008 Mar; 20(3):177-84. PubMed ID: 18257767
[TBL] [Abstract][Full Text] [Related]
14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial drug discovery: is it all downhill from here?
Projan SJ; Shlaes DM
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial drug development--the past, the present, and the future.
Powers JH
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():23-31. PubMed ID: 15522037
[TBL] [Abstract][Full Text] [Related]
17. Growing pains in AIDS drug development.
Herrera S
Nat Biotechnol; 2004 Oct; 22(10):1194. PubMed ID: 15470440
[No Abstract] [Full Text] [Related]
18. Clinical pharmacology considerations in development of gastrohepatology products.
Lee SC; Apparaju S; Kim I; Estes K; Jappar D; Bashaw ED
Clin Pharmacol Ther; 2012 Sep; 92(3):281-3. PubMed ID: 22910484
[TBL] [Abstract][Full Text] [Related]
19. Conducting clinical trials in pediatrics.
Macrae D
Crit Care Med; 2009 Jan; 37(1 Suppl):S136-9. PubMed ID: 19104213
[TBL] [Abstract][Full Text] [Related]
20. Drug development and IBS drugs: experience from the past, current challenges, and proposal for the future.
Camilleri M
Curr Opin Pharmacol; 2008 Dec; 8(6):671-6. PubMed ID: 18588997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
